Response to Dawson et al: Letter to the Editor on ‘‘A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK’’

"Response to Dawson et al: Letter to the Editor on ‘‘A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK’’." Expert Review of Vaccines, 21(6), pp. 871–872

Declaration of interest

A Vyse, J Campling, C Czudek, G Ellsbury, D Mendes, R-R Reinert are employees of Pfizer, which has an interest in pneumococcal vaccines. M Slack works as a contractor for Pfizer, which has an interest in pneumococcal vaccines. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Additional information

Funding

This paper was funded by Pfizer.